Pain Perception, Patient Satisfaction
Conditions
Brief summary
The purpose of this randomized pilot study is to collect preliminary data on the impacts of lavender essential oil aromatherapy on the patient-reported quality of pain management provided for the vascular surgery patient population. The investigators hypothesize that individuals who use a lavender aromastick as a part of their pain management plan will report improved perceptions of the quality of their pain management as measured by the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R). Subjects will be randomized to the control (empty aromastick) and intervention group (aromastick infused with lavender oil), and will use this device as an addition to their pain management plan. Additionally, this pilot study will allow the researchers to evaluate the feasibility of a larger randomized control trial, assess the validity of the survey tool, and collect feedback from patients on the acceptability of the aromatherapy intervention as a complementary therapy during their hospital stay.
Interventions
COMBINATION_PRODUCTAromastick
Vascular surgery patients will be randomized to either the intervention group and receive a lavender infused aromastick to use as an adjunct to their inpatient pain management plan, or to the control group, given a blank aromastick. Subjects will be blinded to their group.
Sponsors
dōTERRA International
Milton S. Hershey Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Subjects 18 and over admitted to the vascular surgery service line on the Heart and Vascular Progressive Care Unit (HVPCU) 2. Not cognitively impaired 3. Able to perform teach-back of the education regarding safe use of the aromastick 4. Able to demonstrate use of the Numeric Pain Rating Scale (NPRS), as evidenced by their ability to answer the initial NPRS question on the Adult Admission II Form used to admit all patients to the hospital 5. English is the primary language, as identified by the Adult Admission II Form
Exclusion criteria
1. Subjects who are unable to consent themselves 2. Subjects who cannot provide teach-back on the safe use of the aromastick 3. Subjects unable to use the NPRS to rate their pain 4. Research team member and/or bedside nurse assess that subject has a cognitive deficit that would prohibit safe use of the aromastick 5. Subjects on suicide precautions 6. Pregnant subjects 7. Prisoners 8. Individuals under age 18 9. Subjects with a current plan to use personal aromatherapy devices during their inpatient stay 10. Subjects with known lavender allergy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary endpoints for this study are patients' self-reported evaluations of the quality of pain management provided during their hospital stay. | Measured on day 6 of hospital stay or day of discharge; whichever is sooner | Measured using the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) survey tool. The APS-POQ-R has 18 primary questions with continuous rating scales from 0 - 10 or from 0% - 100%. This study, with permission from the original authors, uses a modified survey, with 10 questions evaluating the subject's pain levels and degree to which pain interferes with various aspects of their quality of life. In these questions, higher numbers indicate higher levels of pain and distress. Four additional Likert style questions evaluate subjects' satisfaction with pain management, with higher numbers indicating higher levels of satisfaction. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subjects' evaluation of the aromastick | Measured on day 6 of hospital stay or day of discharge; whichever is sooner | Survey questions will also be asked about use of the aromastick to evaluate acceptability of the intervention device. These are yes/no questions, and questions measuring the frequency of device use. |
Countries
United States
Outcome results
None listed